Page URL:

Human trial to use stem cells to treat spinal cord injury

18 October 2010
Appeared in BioNews 580

A patient paralysed through spinal cord injury has become the first person to receive human embryonic stem cell (ES cell) treatment in a clinical trial being conducted in the United States. The anonymous patient was injected with stem cells at the site of injury in the hope that the cells will repair the damaged nerve tissue to restore some movement. 

The clinical trial, which involved cells derived from embryos under 14 days old, is being run by the Californian biotechnology company, Geron Corporation. Stem cells have already been used for therapeutic purposes, but this is the first time embryonic stem cells, rather than adult cells, have been used in humans as part of a regulated clinical trial.

'Initiating the GRNOPC1 clinical trial is a milestone for the field of human embryonic stem cell-based therapies', said Dr Thomas Okarma, chief executive of Geron. 'When we started working with human ES cells in 1999, many predicted that it would be a number of decades before a cell therapy would be approved for human clinical trials'.

The clinical trial involves isolating ES cells before growing them into oligodendrocyte progenitor cells (OPCs). Whilst ES cells have the potential to develop into any cell type in the human body, known as pluripotency, OPCs have developed beyond this stage and will turn only into nervous system cells, including oligodendrocytex. Previous studies have shown this reduces the risk of excessive cell growth, which can develop into tumours. By injecting OPCs at the site of injury, it is believed the cells will develop into new oligodendrocytes, restoring function to the damaged nerve cells.

'This is indeed a significant milestone in our journey towards the promise of stem cell-based medicines', said Dr Ben Sykes, executive director of the UK National Stem Cell Network. 'Geron's commitment to reaching this first stage of phased clinical trials has been rewarded with the first full regulatory approval - at least in the Western world - to proceed with a human embryonic stem cell-based therapy in a human patient'.

Four people each day in the UK sustain spinal cord injuries leading to paralysis. Spinal cord injury is often due to bruising rather than severing of the spinal cord. Bruising results in inflammation, which is responsible for the loss of oligodendrocytes. These cells protect and insulate the nerve cells of the spinal cord and - if lost - cause the nerve cells to stop functioning, leading to paralysis.

The patient was treated at the Shepherd Centre, Atlanta, one of seven American centres taking part in the clinical trial. Professor Sir Ian Wilmut, Director of the Medical Research Council Centre for Regenerative Medicine at the University of Edinburgh said: 'This is very exciting news, however, it is very important to appreciate that the objective of trials at this stage is to confirm first of all that no harm is done to patients, rather than to look for benefits. Once that has been confirmed then the focus moves on to development and assessment of the new treatment'.

Professor Chris Mason, a regenerative biologist at University College London said: 'This pivotal clinical trial is a major morale boost for scientists, clinicians and most of all patients by finally commencing the transformation of stem cells from a scientific curiosity into advanced healthcare'.

First trial of embryonic stem cells in humans
BBC News |  11 October 2010
Geron Initiates Clinical Trial of Human Embryonic Stem Cell-Based Therapy
Geron Corporation |  11 October 2010
Spinal patient is first to get stem cells from embryos in bid to walk again
Daily Mail |  12 October 2010
Stem cell clinical trial aims to combat nerve damage in human tissue
The Guardian |  11 October 2010
Stem cell scientists' bid to help paralysed walk again
Daily Express |  12 October 2010
19 September 2016 - by Dr Greg Ball 
An experimental stem cell therapy appears to have restored some feeling and limb control in five patients paralysed by spinal cord injuries...
21 November 2011 - by Rosemary Paxman 
A US drug company is abandoning its research into a novel paralysis treatment using embryonic stem cells, due to current economic conditions....
23 May 2011 - by Antony Starza-Allen 
A controversial stem cell therapy center operating out of Dusseldorf and Cologne, Germany, has closed. The news follows an undercover investigation by the Sunday Telegraph which claimed that the clinic offered unproven and dangerous stem cell therapies....
21 March 2011 - by MacKenna Roberts 
A US company has launched an experimental neural stem cell clinical trial for patients paralysed by spinal injury. StemCells Inc will extract neural stem cells from donated aborted fetuses to be injected into the spines of patients with chest-level spinal cord injury...
25 October 2010 - by Dr Karen Devine 
This colourful, illustrated guide to stem cells is the perfect companion for any student wishing to gain a greater understanding of stem cell research, use and ethical debates...
23 August 2010 - by Kyrillos Georgiadis 
Japanese researchers have overcome a major obstacle to treating severe spinal cord injuries using stem cells taken from the brain...
23 August 2009 - by Alison Cranage 
The US Food and Drug Administration (FDA) has delayed the start of a clinical trial that plans to use human embryonic stem cell(ES) cells to treat spinal cord injury. The trial is being run by Californian based company Geron. The FDA originally gave the go-ahead for the trial in January, but now has halted the start in order to review new data submitted by Geron....
1 June 2009 - by Dr Rebecca Robey 
Scientists in the US and Korea have announced a new technique for creating embryonic-like stem cells from adult cells. They say that the new method is the first to be completely safe for clinical use and so could bring stem-cell based therapies for a whole host of...
12 May 2009 - by Paul Martin and Emma Rowley 
Regenerative medicine, including stem cells and tissue engineering, holds great hope for the future in terms of addressing the unmet health needs of patients. In particular, much attention has been paid to the potential of novel stem cell based therapies following a series of major scientific breakthroughs and media reports...
22 September 2008 - by Alison Cranage 
Researchers have generated a specialised type of nerve cell - astrocytes - from embryonic stem (ES) cells. The astrocytes were used to treat spinal injury in rats, with impressive results, restoring their ability to move freely. The team of scientists from the University of Rochester, New York, and the...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.